Anthropic has announced the launch of Claude Science, its latest flagship product designed to support scientific research, at an event attended by pharmaceutical executives and biotech founders. Similar to Claude Code, this new product can autonomously perform tasks based on high-level instructions, specifically catering to computational biology and drug development. The launch indicates Anthropic's commitment to enhancing AI applications in science, as the company plans to utilize Claude Science in its own research focused on drugs for rare and neglected diseases. Additionally, discussions on California's controversial carbon offsetting program reveal significant flaws in its approach to climate policy, potentially exacerbating global warming issues.
Anthropic Unveils Claude Science to Advance Scientific Research
More Articles From This Day
Reinforcement Learning with Metacognitive Feedback Enhances Uncertainty Expression in Large Language Models
This research presents a novel approach to improve the metacognitive abilities of large language models (LLMs) through reinforcement learning with metacognitive feedback (RLMF). The study identifies systemic deficiencies in LLMs, such as hallucination with high confidence and misrepresentation of uncertainty, which undermine their reliability. By implementing RLMF, the researchers demonstrate an improvement in the calibration of models' self-reported confidence scores, achieving state-of-the-art results in faithful calibration across diverse tasks. The findings indicate that RLMF not only surpasses standard reinforcement learning methods by up to 63% but also enhances LLMs' self-assessment capabilities, proposing a new paradigm for aligning model performance with intrinsic uncertainty.